G6PC1 and kidney disorder: Furthermore, fenofibrate, via the promotion of fatty acid β‐oxidation, significantly decreased the hepatic and renal glycogen and triglyceride accumulations, and prevented liver injury and nephropathy in L.G6pc−/− and K.G6pc−/− mice.72